Abstract
Activation of the coagulation systems by endotoxin and release of vasoactive agents are both essential for the production of microthrombosis. Glucocorticoids prevent activation of factor XII by endotoxinin vivo and decrease production of tissue factor by macrophages. NSAID do not interfere with factor XII activation and increase the severity and risks of microthrombosis by inhibiting synthesis and release of protective prostaglandins. On the other hand, prolonged administration of glucocorticoids results in the reduction of the immune defence and fibrinolysis, increases the α-adrenergic response to endotoxin and sensitizes to endotoxin-induced intravascular coagulation like NSAID.
Similar content being viewed by others
References
D.G. McKay,Disseminated Intravascular Coagulation. An Intermediary Mechanism of Disease. Hoeber Medical Div., Harper and Row Publishers 1965.
J.G. Latour,Adrenergic stimulations and glomerular capillary thrombosis, Lab. Invest.44, 37 (1981) (Abstr.).
J.G. Latour, C. Gauthier andM. Cantin,Angiotensin II and glomerular capillary thrombosis, Fedn Proc.40, 772 (1981) (Abstr.).
J.G. Latour,Prostaglandins and disseminated intravascular coagulation, Lab. Invest.40, 267 (1979) (Abstr.).
J.G. Latour, C. Léger-Gauthier andJ. Daoust-Fiorilli,Vasoactive agents and production of thrombosis during intravascular coagulation. 1 Comparative effects of norepinephrine in thrombin and adenosine diphosphate treated rabbits (In preparation).
L. Thomas andR.A. Good,Bilateral cortical necrosis of kidney in cortisone treated rabbits following injection of bacterial endotoxin, Proc. Soc. exp. Biol. Med.76, 604–608 (1951).
J.G. Latour, J.B. Préjean andW. Margaretten,Corticosteroids and the generalized Shwartzman reaction. Mechanisms of sensitization in the rabbit, Am. J. Path.65, 189–201 (1971).
J.G. Latour andC. Léger-Gauthier,Prostaglandins in the pathogenesis of the generalized Shwartzman reaction, Am. J. Obstet. Gynec.135, 577–580 (1979).
A.M. Dannenberg,The anti-inflammatory effects of glucocorticoids. A brief view of the literature, Inflammation3, 329–343 (1979).
L. Lee andR.T. McCluskey,Immunohistochemical demonstration of the reticuloendothelial clearance of circulating fibrin aggregates, J. exp. Med.116, 611–617 (1962).
G. Muller-Berghaus andH.G. Lash, Microcirculatory disturbances induced by generalized intravascular coagulation. InHandbook of Experimental Pharmacology, vol. 26, part 3 (Eds.J. Schmier andO. Eichler). Springer-Verlag 1975.
H.N. Claman,Corticosteroids and lymphoid cells, N. Engl. J. Med.287, 388–397 (1972).
J.G. Latour andD.G. McKay,Requirement of the adrenal glands for provocation of the generalized Shwartzman reaction, Lab. Invest.22, 281–285 (1970).
J.G. Latour andC. Léger-Gauthier,Sensitization to the generalized Shwartzman reaction by catecholo-methyltransferase inhibitors, Am. J. Path.92, 377–387 (1978).
D.L. Hall, J.S. Broom andJ.G. Brunson,Effects of epinephrine tolerance on the Shwartzman phenomenon, Am. J. Path.44, 431–440 (1964).
R.M. Nalbandian andR.L. Henry,Plateletendothelial cell interactions. Metabolic maps of structures and actions of prostaglandins, prostacyclin, thromboxane and cyclic AMP, Sem. Thrombosis Hemost.5, 87–111 (1978).
J.G. Latour andC. Groulx,Antiplatelet drugs and the generalized Shwartzman reaction in the pregnant rat, J. Pharmac. exp. Ther.211, 171–173 (1979).
J.G. Latour andJ.P. Clozel,Mechanism of prevention of the generalized Shwartzman reaction in the pregnant rat by prostacyclin (PGI2) (In preparation).
S. Renaud, Influence of corticoids on coagulation and thrombosis in rat: possibility of a serum-protein related effect. InEndocrine Aspects of Disease Processes (Ed.G. Jasmin). W.H. Green Inc., St Louis 1968.
F. Dreyfuss andJ. Menczel,The effects of corticotrophin, cortisone and prednisolone on whole blood coagulation time, J. Lab. clin. Med.51, 530–538 (1958).
S.W. Cosgriff,Thromboembolic complications associated with ACTH and cortisone therapy, J. Am. med. Ass.147, 924–929 (1951).
J.G. Latour andC. Léger,Prevention by glucocorticoids of disseminated intravascular coagulation induced by endotoxin: mechanisms, J. Lab. clin. Med.85, 934–949 (1975).
S. Renaud andJ.G. Latour,Prevention by a glucocorticoid of the thrombotic and hemorrhagic tendencies consecutive to shock and surgical interventions in rat, Thromb. Diath. haemorrh.21, 151–158 (1969).
J.G. Latour, C. Léger andS. Renaud,Activation of Hageman factor and initiation of hepatic vein thrombosis in the hyperlipemic rat, Am. J. Path.76, 179–193 (1974).
J.G. Latour, C. Léger andS. Renaud,On the mechanisms responsible for selection of hepatic veins as target for thrombosis following injection of endotoxin in hyperlipemic rats, Am. J. Path.76, 195–212 (1974).
The Hemorrhagic Disorders, p. 222 (Eds.M. Stefanini andW. Dameshek). Grune and Stratton, New York 1955.
S. Renaud, C. Allard andJ.G. Latour,The prevention by glucocorticoids of endotoxin-initiated thrombosis in the rat, in relation to fibrinolysis, coagulation and lipemia, Am. Heart J.72, 797–805 (1966).
Z. Werb,Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase and plasmin activator and effects on other metabolic functions, J. exp. Med.147, 1695–1712 (1978).
W. Margaretten, H.O. Zucker andD.G. McKay,Production of the generalized Shwartzman reaction in pregnant rats by intravenous infusion of thrombin, Lab. Invest.13, 552–559 (1964).
J.G. Latour, C. Groulx andC. Léger-Gauthier Activation of the Hageman factor-prekallikrein system in the pathogenesis of the generalized Schwartzman reaction and of the hepatic vein thrombosis, phenomenon in the rat, Lab. Invest.41, 237–246 (1979).
J.G. Latour, D.G. Mckay andK. Nasu,Prevention of the generalized Schwartzman reaction by glucocorticoids, Am. J. Obstet. Gynec.113, 863–867 (1972).
C.F. Slabber, W. Theiss andF.K. Beller,The prevention of endotoxin-induced glomerular fibrin deposition by pyrimido-pyrimidine compounds, J. Med.3, 341–348 (1972).
J.G. Latour andF. Bernard,Prevention by aspirin of the classic generalized Shwartzman reaction, Am. J. Path.91, 595–606 (1978).
B. Ghebrehiwet, M. Silverberg andA.P. Kaplan,Activation of human complement by Hageman factor fragments, Fedn Proc.40, 967 (1981) (Abstr.).
J.M. Bergstein andA.F. Michael Jr,Failure of cobra venom to prevent the generalized Shwartzman reaction and loss of renal cortical fibrinolytic activity, Am. J. Path.74, 19–30 (1974).
J.J. Corrigan Effects of anticoagulating and non-anticoagulating concentrations of heparin on the generalized Shwartzman reaction, Thromb. Diath. haemorrh.24, 136–145 (1970).
U.S. Public Health Service,Standardized Diagnostic Complement Titration and Adaptation to Microtest. Public Health Service publication 1228, monograph74, U.S. Government Printing Office, Washington, D.C. 1965.
S.C.L. Hong andL. Levine Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids, Proc. natn. Acad. Sci. USA73, 1730–1734 (1976).
W.R. Nelson andG.A. Taylor,In vitro inhibition of endotoxin induced platelet aggregation with hydrocortisone sodium succinate (Solu-Cortef), Scand. J. Haematol.15, 35–44 (1975).
J.G. Latour, C. Léger-Gauthier andC. Groulx,Prevention of the generalized Shwartzman reaction by bradykinin and prostaglandins, Thromb & Hemost.38, 224 (1977) (Abstr.).
J.G. Latour andS. Renaud,Prevention by glucocorticoids of various blood parameter changes following surgical intervention and endotoxin administration in the rat, Can. med. Ass. J.100, 20–26 (1969).
M. Szczepanski andC. Lucer,The influence of large doses of hydrocortisone on the generalized Shwartzman reaction in rabbit, Thromb. Res.8, 71–81 (1976).
W. Margaretten, J. Elting, J. Rothenberg andD. G. McKay,Experimental adrenal hemorrhage in the generalized Shwartzman reaction, Lab. Invest.14, 687–691 (1965).
R.L. Prager, E.L. Dunn andJ.F. Seaton,Increased adrenal secretion of norepinephrine and epinephrine after endotoxin and its reversal with corticosteroids, J. Surg, Res.18, 371–375 (1975).
M.I. Barnhart andC.A. Baechler,Endothelial cell physiology, perturbations and responses, Sem. Thromb. Hemost.5, 50–86 (1978).
M.I. Barnhart andS.T. Chen,Vessel wall models for studying interaction capabilities with blood platelets, Sem. Thromb. Hemost.5, 112–155 (1978).
G. Muller-Berghaus,The role of platelets, leukocytes, and complement in the activation of intravascular coagulation by endotoxin, InPlatelets: A Multidisciplinary Approach, pp. 303–320 (Eds.G. De Gaetano andS. Garattini). Raven Press, New York 1978.
E. Amlie, T. Lyberg, A. Kaplun, O. Hetland andH. Pridz,Thromboplastin activity of mouse peritoneal macrophages, Thromb. Res.24, 61–71 (1981).
H. Vinazzer,Assay of total factor XII and of activated factor XII in plasma with a chromogenic substrate, Thromb. Res.14, 155–166 (1979).
J.G. Latour, C. Léger andS. Renaud,Activation of Hageman factor and initiation of hepatic vein thrombosis in the hyperlipemic rat, Am. J. Path.76, 179–192 (1974).
F. Skjorten andS.A. Evensen,Induction of disseminated intravascular coagulation in the factor XII-deficient fowl: morphological effects of liquiod, bacterial endotoxin and tissue thromboplastin in the normal and anticoagulated fowl, Thromb. Diath. haemorrh.30, 25–35 (1973).
D.G. McKay, J.G. Latour andA.M. Lopez,Production of the generalized Shwartman reaction by activated Hageman factor and α-adrenergic stimulation, Thromb. Diath. haemorrh.26, 71–76 (1971).
G. Muller-Berghaus andD.G. McKay,Prevention of the generalized Schwartzman reaction in pregnant rat by α-adrenergic blocking agents, Lab. Invest.17, 276–280 (1967).
Author information
Authors and Affiliations
Additional information
Supported by Grant MT-4478 of the Medical Research Council; presented at the ‘Fourth European Workshop on Inflammation’, Antwerp, Belgium, March 1982.
Rights and permissions
About this article
Cite this article
Latour, JG. Modulation of disseminated intravascular coagulation (DIC) by steroidal and non-steroidal anti-inflammatory drugs. Agents and Actions 13, 487–495 (1983). https://doi.org/10.1007/BF02176420
Issue Date:
DOI: https://doi.org/10.1007/BF02176420